| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 06/11/2019 | 23h03 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/11/2019 | 16h30 | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 06/11/2019 | 16h30 | Edgar (US Regulatory) | Unknown (sec Staff) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 29/08/2019 | 22h31 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 29/08/2019 | 12h46 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/08/2019 | 13h02 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/08/2019 | 12h44 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 10/06/2019 | 15h32 | Edgar (US Regulatory) | Certification by the Exchange Approving Securities for Listing (cert) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h56 | Edgar (US Regulatory) | Securities Registration (section 12(b)) (8-a12b) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h41 | Edgar (US Regulatory) | Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeeme... | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 22h13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 07/06/2019 | 20h20 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 29/05/2019 | 18h58 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 28/05/2019 | 22h10 | GlobeNewswire Inc. | Rexahn Announces Move to Nasdaq | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 13/05/2019 | 14h00 | GlobeNewswire Inc. | Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 10/05/2019 | 22h22 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 29/04/2019 | 22h45 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 16/04/2019 | 14h04 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 16/04/2019 | 14h00 | GlobeNewswire Inc. | Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 12/04/2019 | 14h16 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 12/04/2019 | 14h00 | GlobeNewswire Inc. | Rexahn Effects 1-for-12 Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 10/04/2019 | 22h07 | GlobeNewswire Inc. | Rexahn Announces Reverse Stock Split | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 27/03/2019 | 13h00 | GlobeNewswire Inc. | Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual Meeting | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 26/03/2019 | 21h15 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |
| 11/03/2019 | 11h55 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:RNN | Rexahn Pharmaceuticals, Inc. |